• Candel Therapeutics granted General Counsel Maria Ostrovsky stock options to purchase 315,000 common shares on November 3, 2026.
• The options vest 25% on the first anniversary of her start date, with the remaining 75% vesting in 36 equal monthly installments.
• All vesting is subject to Ostrovsky's continued service through each applicable vesting date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Candel Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611051605PRIMZONEFULLFEED9871693) on November 05, 2026, and is solely responsible for the information contained therein.